↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Wahlin A) ;srt2:(2015-2019)"

Sökning: WFRF:(Wahlin A) > (2015-2019)

Resultat 21-30 av 33

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
21.	Fordell, H, et al. (författare) REHABILITATION IN CHRONIC NEGLECT USING VR STRENGTHENS CONNECTIVITY BETWEEN NODES OF THE DORSAL ATTENTION NETWORK 2018 Ingår i: INTERNATIONAL JOURNAL OF STROKE. - 1747-4930. ; 13, s. 50-50 Konferensbidrag (övrigt vetenskapligt/konstnärligt)
22.	Hagberg, Hans, et al. (författare) Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study 2015 Ingår i: Leukemia. - : Springer Science and Business Media LLC. - 0887-6924 .- 1476-5551. ; 29:3, s. 668-676 Tidskriftsartikel (refereegranskat)abstract Treatment for follicular lymphoma (FL) improved with rituximab. In Sweden, first-line rituximab was gradually introduced between 2003 and 2007, with regional differences. The first national guidelines for FL were published in November 2007, recommending rituximab in first-line therapy. Using the population-based Swedish Lymphoma Registry, 2641 patients diagnosed with FL from 2000 to 2010 were identified and characterized by year and region of diagnosis, age (median, 65 years), gender (50% men), first-line therapy and clinical risk factors. Overall and relative survivals were estimated by calendar periods (2000-2002, 2003-2007 and 2008-2010) and region of diagnosis. With each period, first-line rituximab use and survival increased. Survival was superior in regions where rituximab was quickly adopted and inferior where slowly adopted. These differences were independent in multivariable analyses. Ten-year relative survival for patients diagnosed 2003-2010 was 92%, 83%, 78% and 64% in the age groups 18-49, 50-59, 60-69 and ≥70, respectively. With increasing rituximab use, male sex emerged as an adverse factor. Survival improved in all patient categories, particularly in elderly women. The introduction and the establishment of rituximab have led to a nationwide improvement in FL survival. However, rituximab might be inadequately dosed in younger women and men of all ages. © 2015 Macmillan Publishers Limited. All rights reserved.
23.	Helling, G, et al. (författare) Plasma Glutamine Concentrations in Liver Failure 2016 Ingår i: PloS one. - : Public Library of Science (PLoS). - 1932-6203. ; 11:3, s. e0150440- Tidskriftsartikel (refereegranskat)
24.	Karalli, A, et al. (författare) Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting 2019 Ingår i: Scandinavian journal of gastroenterology. - : Informa UK Limited. - 1502-7708 .- 0036-5521. ; 54:7, s. 905-912 Tidskriftsartikel (refereegranskat)
25.	Lindqvist, C, et al. (författare) Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography 2019 Ingår i: Nutrition (Burbank, Los Angeles County, Calif.). - : Elsevier BV. - 1873-1244 .- 0899-9007. ; 61, s. 93-98 Tidskriftsartikel (refereegranskat)
26.	Lindqvist, C, et al. (författare) Body composition assessed by dual-energy X-ray absorptiometry predicts early infectious complications after liver transplantation 2017 Ingår i: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. - : Wiley. - 1365-277X. ; 30:3, s. 284-291 Tidskriftsartikel (refereegranskat)
27.	Lockmer, S, et al. (författare) Sequential Immune Cell Modulation in Nordic Follicular Lymphoma Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide 2015 Ingår i: BLOOD. - 0006-4971. ; 126:23 Konferensbidrag (övrigt vetenskapligt/konstnärligt)
28.	Mulder, TA, et al. (författare) Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application 2019 Ingår i: Cancers. - : MDPI AG. - 2072-6694. ; 11:7 Tidskriftsartikel (refereegranskat)abstract In lymphomas of B-cell origin, cancer cells orchestrate an inflammatory microenvironment of immune and stromal cells that sustain the tumor cell survival and growth, known as a tumor microenvironment (TME). The features of the TME differ between the different lymphoma types, ranging from extremely inflammatory, such as in Hodgkin lymphoma, to anergic, leading to immune deficiency and susceptibility to infections, such as in chronic lymphocytic leukemia. Understanding the characteristic features of the TME as well as the interactions between cancer and TME cells has given insight into the pathogenesis of most lymphomas and contributed to identify novel therapeutic targets. Here, we summarize the preclinical data that contributed to clarifying the role of the immune cells in the TME of different types of lymphomas of B-cell origin, and explain how the understanding of the biological background has led to new clinical applications. Moreover, we provide an overview of the clinical results of trials that assessed the safety and efficacy of drugs directly targeting TME immune cells in lymphoma patients.
29.	Muratori, P, et al. (författare) Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 2017 Ingår i: European journal of gastroenterology & hepatology. - 1473-5687. ; 29:7, s. 777-780 Tidskriftsartikel (refereegranskat)
30.	Steen, CB, et al. (författare) A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy 2019 Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 1592-8721 .- 0390-6078. ; 104:10, s. E460-E464 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 21-30 av 33

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (29); konferensbidrag (4)

Typ av innehåll: refereegranskat (26); övrigt vetenskapligt/konstnärligt (7)

Författare/redaktör: Farrell, S. (1); Fischer, J. (1); Schmitt, C. (1); Werner, M. (1); Turesson, I (1); Wang, M. (1); visa fler...; Osterborg, A (1); Jonsson, L. (1); Aaron-Morrison, Arle ... (1); Ackerman, Steven A. (1); Allan, Rob (1); Alves, Lincoln M. (1); Amador, Jorge A. (1); Andreassen, L. M. (1); Arndt, Derek S. (1); Arzhanova, N. M. (1); Azorin-Molina, César (1); Bardin, M. U. (1); Barichivich, Jonatha ... (1); Baringer, Molly O. (1); Barreira, Sandra (1); Baxter, Stephen (1); Becker, Andreas (1); Bedka, Kristopher M. (1); Behrenfeld, Michael ... (1); Bell, Gerald D. (1); Belmont, M. (1); Benedetti, Angela (1); Berrisford, Paul (1); Berry, David I. (1); Bettolli, María L. (1); Bhatt, U. S. (1); Bidegain, Mario (1); Bissolli, Peter (1); Blake, Eric S. (1); Blunden, Jessica (1); Bosilovich, Michael ... (1); Boucher, Olivier (1); Boudet, Dagne (1); Box, J. E. (1); Boyer, Tim (1); Braathen, Geir O. (1); Bromwich, David H. (1); Brown, R. (1); Bulygina, Olga N. (1); Burgess, D. (1); Calderón, Blanca (1); Camargo, Suzana J. (1); Campbell, Jayaka D. (1); Cappelen, J. (1); visa färre...

Lärosäte: Karolinska Institutet (31); Umeå universitet (6); Uppsala universitet (4); Göteborgs universitet (3); Lunds universitet (3); Örebro universitet (1); visa fler...; Jönköping University (1); visa färre...

Språk: Engelska (33)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (9); Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy